However, Carragher thinks that Amorim simply cannot afford to play Matthijs de Ligt or Harry Maguire in the right-sided centre back role. Carragher fears that they are too slow to cope with being ...
Jet van Nieuwkerk is opnieuw in verwachting. Dat nieuws deelt de 35-jarige dochter van Matthijs van Nieuwkerk in een bericht op sociale media.
Former Manchester United defender Jaap Stam has claimed that summer signing Matthijs de Ligt with be a major beneficiary of Ruben Amorim’s tactics at Old Trafford. It was announced officially ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...
Fintel reports that on October 31, 2024, Morgan Stanley downgraded their outlook for Biogen (SNSE:BIIBCL) from Overweight to Equal-Weight. There are 1,775 funds or institutions reporting positions ...
Biogen Inc. ( (BIIB)) has realeased its Q3 earnings. Here is a breakdown of the information Biogen Inc. presented to its investors. Biogen Inc. is a leading biotechnology company that specializes ...
Bio­gen’s in­vestors are grow­ing rest­less. Wednes­day’s third-quar­ter earn­ings call checked most of the box­es for a suc­cess­ful re­port. The com­pa­ny raised its full-year ...
Despite a somewhat ambling launch, Biogen’s Eisai-partnered Alzheimer’s disease drug Leqembi continues to grow. But to truly unlock the amyloid-busting antibody’s potential, the company will ...
Biogen Raises Forecast as Alzheimer’s Drug Leqembi Shows Signs of Growth Quarterly Leqembi sales reached $67 million, beating estimates Cost cuts to drive high-teen percentage operating income boost ...
(Bloomberg) -- Biogen Inc. raised its annual earnings guidance after reporting better-than-expected third-quarter sales and profit, driven by ongoing cost-cutting measures and the strong performance ...
Biogen is the latest big biotech to make a play in protein degradation. The Massachusetts-based company has announced a deal to use Neomorph’s molecular glue degrader discovery platform to go ...